Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

French NutriNet-Santé Study: Natural Food Color Additives Linked to 38–49% Higher Type 2 Diabetes Risk and Increased Cancer Rates

French NutriNet-Santé studies: natural food colorants linked to 38–49% higher T2D risk and 14–32% higher cancer risk. Beta-carotene, curcumin, anthocyanins all implicated.

Medical Daily

One Historic Week for Flu: Generic Xofluza Approved June 17, mRNA Flu Vaccine VRBPAC Vote June 18 — Here's What Both Mean for 2026–27

FDA approved generic baloxavir June 17; VRBPAC voted on mRNA flu vaccine June 18. The 2025–26 flu season killed 24,000 Americans. Here's what both mean for 2026–27.

Medical Daily

FDA Authorized an OTC Treatment for New World Screwworm in Pets — Here's How to Use Nitenpyram if Your Dog or Cat Is Infested

FDA issued EUA for generic nitenpyram June 11, 2026 to treat New World screwworm in dogs and cats. CDC Level 3 EOC active. 12+ animal cases confirmed in TX and NM.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA Approves First Generic Baloxavir (Xofluza): Single-Dose Flu Treatment Now Available at Generic Price

FDA approved the first generic baloxavir marboxil (Xofluza) on June 17, 2026. Norwich Pharmaceuticals developed the single-dose flu treatment for patients 5 and older.

Medical Daily

Huntington's Disease Gene Therapy AMT-130 Is on Track for FDA Approval After uniQure Reaches Regulatory Agreement

uniQure announced June 17, 2026: FDA agreed that 3-year AMT-130 Phase I/II data supports an accelerated approval BLA for Huntington's disease. BLA submission planned Q3 2026.

Medical Daily

Alembic Pharma gets tentative nod from USFDA for generic cancer drug

Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step for the company in the cancer treatment drug market. The approval is for the 45mg strength, with potential for marketing exclusivity. Alembic previously received tentative approval for the 15mg strength. Binimetinib…

The Economic Times

USFDA concludes inspection at Jubilant HollisterStier's Spokane plant with 8 observations

Jubilant Pharmova announced its US subsidiary, Jubilant HollisterStier LLC, underwent a USFDA inspection. The facility in Spokane, Washington, received eight observations. These observations do not involve sterility assurance concerns. The company will submit its response to the US health regulator within 15 business days. Jubilant Pharmova is committed to addressing…

The Economic Times

Read news from The Economist, FT, and more,
with one subscription

Tennessee Became the First State to Let Pharmacies Sell Ivermectin without a Prescription. Here's What That Looks Like Now.

KFF Health News June 17 investigation: Tennessee pharmacies sell ivermectin 10–21x standard potency via one anti-vaccine doctor's blanket prescriptions. 60+ poison center calls in 2025.

Medical Daily

Premature Infants in NICUs Are Among the Most DEHP-Exposed Humans on Earth — and the New Anxiety Study Makes That Urgent

NICU premature infants face intensive DEHP exposure via PVC medical tubing and IV bags. ENDO 2026 data shows prenatal/postnatal DEHP causes lasting anxiety. Here's the accountability gap.

Medical Daily

Texas A&M Scientists Unlocked the Human Body's Hidden Ability to Regrow Bone and Joints — Using Two Already-Approved Signals

Texas A&M / Nature Communications June 17, 2026: FGF2 + BMP2 sequential treatment regrew bone, joint, cartilage, and ligaments in mice that normally scar. What it means for medicine.

Medical Daily

FDA panel backs first-of-its-kind flu vaccine using mRNA technology

A new kind of flu vaccine is moving a step closer to the U.S. market

AAP

uniQure Stock Looks Drastically Undervalued After Upbeat FDA Meeting

uniQure stock looks poised to soar over the long term, but it does pose meaningful risk.

Barchart

Popular Antidepressant Recalled Over Cancer-Causing Chemical, Nearly 370,000 Bottles Affected

Nearly 370,000 bottles of duloxetine have been recalled in the US due to elevated levels of a potentially cancer-causing impurity.

International Business Times UK

FDA Advisory Panel Votes Today on First mRNA Flu Vaccine as MFLUSIVA Phase 3 Results Face Intense Scrutiny

FDA VRBPAC votes June 18 on Moderna's MFLUSIVA — the first mRNA flu vaccine. Phase 3 showed 26.6% RVE vs. standard dose; 47.9% vs. healthcare outcomes. PDUFA August 5, 2026.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

AAP

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

U.S. health advisers are debating a new kind of flu vaccine

The Independent UK

New mRNA flu vaccine faces scrutiny ahead of key FDA decision

U.S. health advisers are debating a new kind of flu vaccine

Reason

How the FDA Created a Peptide Black Market

Because the agency has banned most peptides, products from overseas labs dominate the market. How does that protect Americans?

Fortune

Exclusive: A 21-year-old Stanford grad just raised $11 million to put a hormone lab on your wrist

As Oura and WHOOP expand into women's health, startup Clair Health has raised $11 million to build a wearable designed from the ground up to continuously model hormonal cycles.

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

CDC Activates Emergency Operations Center Following New World Screwworm Detection in Texas as Experts Assess Potential Threats to Humans

CDC activated emergency operations June 16 for New World screwworm in Texas and New Mexico. 12 animal cases confirmed. Human risk low but real. What to watch for.

Medical Daily

FDA Approves Xocova (Ensitrelvir): The First Oral COVID Pill You Take After Exposure — Before You Get Sick

Xocova (ensitrelvir) is the first FDA-approved oral COVID post-exposure pill, cutting risk by 67% in the SCORPIO-PEP Phase 3 trial. What high-risk patients need to know.

Medical Daily

A Smart Ring That Diagnoses Sleep Apnea at Home with 97% Accuracy Just Got FDA Cleared — Here's How It Works

The FDA-cleared Happy Ring diagnoses sleep apnea at home with 97% accuracy. Up to 30M Americans have undiagnosed OSA. Here's what this means for your health.

Medical Daily

The FDA Just Put Psilocybin and an MDMA-Like Drug on a 1-to-2 Month Approval Track. A Historic Mental Health Decision Is Coming.

FDA issued National Priority Vouchers to Compass Pathways, Usona, and Transcend for psilocybin and methylone in April 2026. A decision could come by late 2026.

Medical Daily

Hepatitis Delta Is the Deadliest Form of Viral Hepatitis — and the U.S. Just Got Its First Treatment for It

FDA granted accelerated approval to Hepcludex (bulevirtide) for Hepatitis Delta on May 22, 2026 — the first-ever U.S. treatment for HDV. What patients need to know.

Medical Daily

Nara Organics Baby Formula Recalled After 3 Infants Hospitalized with Botulism in California, Pennsylvania, and Washington

FDA and CDC link 3 infant botulism cases to Nara Organics formula sold at Target. All lots recalled. Learn what parents must do now.

Medical Daily

Superfood Supplement Powder Linked to Active Multistate Salmonella Outbreak, Exposing Health Risks Many Buyers Do Not Know About

FDA updated its moringa leaf powder Salmonella outbreak investigation (ref #1358) on June 3, 2026, adding recalled products. The multistate outbreak has 88% of interviewed victims reporting moringa consumption. Products include Live It Up Super Greens and Why Not Natural Moringa capsules. Here is the consumer warning.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.